Photodynamic therapy (PDT), the treatment of disease
with light and a light-activated therapeutic agent, has made strides towards
a more general clinical acceptance over the past decade, but still has
not reached the stage where it is recognized as a first line or primary
treatment for solid subcutaneous cancerous tumors by most clinicians,
including most surgeons and radiation oncologists. Until now.